rxLicense

License Required

wishlistAlt
Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Compare
View Alternative

Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

58160082730 | USAMP#67317086

container type

Single-Dose Vial

volume

0.5 mL

dosage form

Injection

strength

10 mcg - 5 mcg / 0.5 mL

Product Description

  • MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135
  • MENVEO does not prevent N. meningitidis serogroup B infections
  • Single-vial presentation

Product Specification

Manufacturer SKU

58160082730

NDC Code

58160082730

Manufacturer

Glaxo Smith Kline

Brand

Menveo®

USAMP SKU

USAMP#67317086

Application

Meningitis Vaccine

UNSPSC Code

51201610

Country Of Origin

Unknown

Storage Requirements

Requires Refrigeration

User

Indicated for People 10 Years Through 55 Years of Age

Volume

0.5 mL

Strength

10 mcg - 5 mcg / 0.5 mL

Container Type

Single-Dose Vial

Type

Intramuscular

Dosage Form

Injection

Generic Drug Code

53066

Generic Drug Name

Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine